New ÖGMBT company member

Monday, 03 October 2022 02:01
We welcome our new ÖGMBT Company Member: Ludwig Boltzmann Gesellschaft Career Center (LBG-CC)    LBG Career Center – We care for Pre- & Post-Docs We support (young) researchers in Austria in achieving their individual career goals – in or outside of academia. Contact us for a career chat, join our workshops or special programs and design your own unique career path! We empower you to enhance your knowledge and skills for your next career steps and to expand your network. Apply for our next program “Digital Transformation for Researchers” until October 16 and dive deeper into the world of Digitization & Data Science.  

New ÖGMBT company members

Thursday, 08 September 2022 10:55
We welcome our new ÖGMBT Company Members: PHIO scientific GmbH, The Core Facilities of the University of Natural Resources and Life Sciences (BOKU), Ribbon Biolabs, VALIDOGEN, DirectSens, The Doctoral School in Microbiology and Ecosystem Science       PHIO scientific GmbH is a high tech company from Munich, one of th e leading biotech-hubs in Europe. Our fully automatic, super compact microscopes and cutting-edge AI analysis platform allow for continuous imaging inside the incubator and tracking of cell growth, viability, motility and phenotype - on the fly. Our mission is to boost cell culture quality and cell-based research.    The Core Facilities of the University of Natural Resources and Life Sciences (BOKU), Vienna centrally provide infrastructure and expertise from a broad range of different scientific disciplines, covering fields such as biochemical and biomolecular analyses, microscopy, bioinformatics, as well as bioprocess and food engineering. Our services are available for everyone: BOKU internal…
Das neue Erklärvideo von Open Science "SARS-CoV-2: Totimpfstoffe" ist fertig - rechtzeitig zum Start der Impfung mit dem Proteinimpfstoff von Novavax! Das Video, das in Kooperation mit dem Doktoratskolleg RNA-Biologie und der FH Campus Wien entstanden ist, erklärt, wie inaktivierte Ganzvirus- und Proteinimpfstoffe gegen COVID-19 hergestellt werden, was sie beinhalten und wie sie wirken.    

Page 1 of 8